MedPath
NMPA Approval

Metformin Hydrochloride and Empagliflozin Tablets(Ⅵ)

国药准字H20249745

December 17, 2024

Drug Information

二甲双胍恩格列净片(Ⅵ)

片剂

每片含盐酸二甲双胍1000mg与恩格列净12.5mg

化学药品

December 17, 2024

Company Information

Applicant Company

浙江省杭州市钱塘区白杨街道11号大街10号

Manufacturing Company

浙江省杭州经济技术开发区11号大街10号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

二甲双胍恩格列净片(Ⅵ) - NMPA 批准文号 | MedPath